261 related articles for article (PubMed ID: 14708879)
1. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease.
Schwedhelm E; Böger RH
Clin Chem Lab Med; 2003 Dec; 41(12):1552-61. PubMed ID: 14708879
[TBL] [Abstract][Full Text] [Related]
2. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.
Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297
[TBL] [Abstract][Full Text] [Related]
3. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571
[TBL] [Abstract][Full Text] [Related]
4. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.
Leung KS; Galano JM; Durand T; Lee JC
Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341
[TBL] [Abstract][Full Text] [Related]
5. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
Tsikas D; Suchy MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():191-201. PubMed ID: 25583542
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry.
Lee YY; Galano JM; Oger C; Vigor C; Guillaume R; Roy J; Le Guennec JY; Durand T; Lee JC
Lipids; 2016 Nov; 51(11):1217-1229. PubMed ID: 27671161
[TBL] [Abstract][Full Text] [Related]
8. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
[TBL] [Abstract][Full Text] [Related]
9. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
Mori TA; Croft KD; Puddey IB; Beilin LJ
Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
[TBL] [Abstract][Full Text] [Related]
10. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
11. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
[TBL] [Abstract][Full Text] [Related]
12. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods].
Berdeaux O; Scruel O; Durand T; Cracowski JL
Pathol Biol (Paris); 2005 Jul; 53(6):356-63. PubMed ID: 16004948
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS methods for the detection of isoprostanes (iPF2alpha-III and 8,12-iso-iPF2alpha-VI) as biomarkers of CCl4-induced oxidative damage to hepatic tissue.
Sicilia T; Mally A; Schauer U; Pähler A; Völkel W
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):48-55. PubMed ID: 18160027
[TBL] [Abstract][Full Text] [Related]
14. Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
Lawson JA; Li H; Rokach J; Adiyaman M; Hwang SW; Khanapure SP; FitzGerald GA
J Biol Chem; 1998 Nov; 273(45):29295-301. PubMed ID: 9792628
[TBL] [Abstract][Full Text] [Related]
15. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
Schweer H; Watzer B; Seyberth HW; Nüsing RM
J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
[TBL] [Abstract][Full Text] [Related]
16. Extraction and measurement of prostanoids and isoprostanes: Introduction to Part II.
Patrignani P
Methods Mol Biol; 2010; 644():147-52. PubMed ID: 20645171
[TBL] [Abstract][Full Text] [Related]
17. [LC-MS/MS as a method for the determination of isoprostanes: a brief review].
Król MB; Brzeźnicki S
Med Pr; 2023 May; 74(2):119-125. PubMed ID: 36946654
[TBL] [Abstract][Full Text] [Related]
18. GC-MS Analysis of Lipid Oxidation Products in Blood, Urine, and Tissue Samples.
Barden A; Mori TA
Methods Mol Biol; 2018; 1730():283-292. PubMed ID: 29363082
[TBL] [Abstract][Full Text] [Related]
19. Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
Tacconelli S; Capone ML; Patrignani P
Methods Mol Biol; 2010; 644():165-78. PubMed ID: 20645173
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS Analysis of Lipid Oxidation Products in Blood and Tissue Samples.
Lee YY; Lee JC
Methods Mol Biol; 2018; 1730():83-92. PubMed ID: 29363067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
